Merit Medical Systems, Inc. Financial Ratios — MMSI Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	7.78	5.34	4.21	5.46	5.28	4.17	4.69	5.22	0.58	-1.03	4.85	6.82	8.05	9.33	8.67
Return on Assets (%)	5.64	3.42	2.31	3.11	3.12	2.34	2.68	3.08	0.32	-0.58	2.93	4.5	4.73	5.07	5.03
Return on Capital (%)	6.68	4	3.66	4.47	4.28	3.62	3.76	4.45	- -	- -	3.87	5.8	6.13	6.81	6.48
Return on Invested Capital (%)	7.71	4.52	4.16	4.48	4.39	3.74	3.94	4.4	- -	- -	5.14	6.6	6.13	5.89	6.11
Gross Margin (%)	46.03	46.16	43.28	44.19	43.49	43.89	44.82	44.72	43.46	41.62	45.16	45.1	46.44	47.43	48.7
EBITDA Margin (%)	16.2	13.85	14.34	15.03	14.03	13.11	13.64	14.59	14.46	15.85	16.21	16.79	18.19	19.97	21.13
Operating Margin (%)	10.86	8.14	7.09	7.98	7.12	5.86	6.28	6.71	3.97	4.76	7.29	8.78	10.14	11.51	12.25
Incremental Operating Margin (%)	21.5	-19.91	-0.46	14.61	-6.39	-5.23	8.32	8.72	-17.61	-20.79	29.29	29.74	24.82	28.91	18.55
Pretax Margin (%)	9.15	7	4.42	6.19	5.75	4.2	4.93	5.61	0.22	-1.37	5.02	7.18	8.91	11.06	11.28
Profit Margin (%)	6.41	5	3.69	4.51	4.39	3.33	3.78	4.76	0.55	-1.02	4.51	6.47	7.51	8.87	8.48
Net Income to Common Margin (%)	6.41	5	3.69	4.51	4.39	3.33	3.78	4.76	0.55	-1.02	4.51	6.47	7.51	8.87	8.48
Effective Tax Rate (%)	29.9	28.63	16.48	27.23	23.71	20.74	23.29	15.15	- -	- -	10.13	9.82	15.77	19.76	24.83
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	7.78	5.34	4.21	5.46	5.28	4.17	4.69	5.22	0.58	-1.03	4.85	6.82	8.05	9.33	8.67

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	31	238	249	224	208	324	278	395	524	435	315	269	891	795	822
ST Debt	- -	10	10	10	10	10	19	22	19	20	19	22	12	10	11
LT Debt	31	228	239	214	198	314	259	373	505	415	296	246	879	784	811
Total Debt/EBITDA	0.53	4.35	3.87	2.93	2.73	4.1	2.8	3.07	3.64	2.85	1.81	1.39	3.9	2.93	2.56
Net Debt/EBITDA	0.35	4.17	3.75	2.83	2.67	3.86	2.48	2.55	2.75	1.93	1.01	0.72	1.03	1.3	0.9
Total Debt/EBIT	0.79	7.4	7.82	5.52	5.37	9.16	6.09	6.67	13.27	9.48	4.02	2.66	6.99	5.09	4.42
Net Debt/EBIT	0.53	7.1	7.58	5.34	5.27	8.62	5.38	5.54	10.01	6.41	2.23	1.38	1.85	2.26	1.55
EBITDA to Interest Expense	73.79	90.44	8	8.68	12.21	9	12.84	12.43	11.32	15.28	33.11	30.49	14.75	8.68	12.11
EBITDA-CapEx/Interest Expense	-3.87	90.44	8	8.68	12.21	9	12.84	12.43	11.32	15.28	33.11	30.49	14.75	8.68	12.11
EBIT to Interest Expense	49.47	53.13	3.96	4.61	6.2	4.02	5.91	5.72	3.11	4.59	14.9	15.94	8.22	5	7.02
Interest Expense	1	1	8	9	6	9	8	10	13	10	5	6	16	31	26
Common Equity/Total Assets	79.88	54.1	55.71	58.25	59.85	52.84	60.83	57.58	54.06	57.59	63.08	68.78	51.69	57.03	58.99
Long-Term Debt/Equity (%)	8.61	59.64	58.87	49.28	42.39	63.1	38.3	40	53.13	43.26	28.46	21.54	73.15	56.86	51.17
Long-Term Debt/Capital (%)	7.93	36.75	36.49	32.51	29.33	38.22	27.13	28.1	34.25	29.75	21.84	17.44	42	36.08	33.7
Long-Term Debt/Total Assets (%)	6.88	32.26	32.8	28.71	25.37	33.34	23.3	23.03	28.72	24.91	17.95	14.81	37.81	32.43	30.18
Total Debt/Equity (%)	8.61	62.26	61.34	51.58	44.54	65.11	41.17	42.36	55.13	45.39	30.3	23.48	74.16	57.61	51.86
Total Debt/Capital (%)	7.93	38.37	38.02	34.03	30.81	39.43	29.17	29.76	35.54	31.22	23.25	19.02	42.58	36.55	34.15
Total Debt/Total Assets (%)	6.88	33.68	34.17	30.05	26.66	34.41	25.05	24.39	29.8	26.14	19.11	16.15	38.33	32.86	30.59
Net Debt to Equity	5.77	59.71	59.5	49.89	43.64	61.26	36.39	35.14	41.6	30.7	16.84	12.2	19.63	25.58	18.16
Net Debt/Capital (%)	5.46	37.39	37.3	33.28	30.38	37.99	26.68	26	27.65	22.02	13.6	10.3	15.67	19.63	14.68
EBITDA	58	55	64	77	76	79	99	129	144	153	174	193	229	271	320
EBITDA-CapEx	-3	55	64	77	76	79	99	129	144	153	174	193	229	271	320
Operating Income (Loss)	39	32	32	41	39	35	46	59	39	46	78	101	127	156	186

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.23	0.13	0.11	0.1	0.05	0.22	0.28	0.38	0.24	0.31	0.29	0.26	2.88	1.74	1.86
Current Ratio	3.05	2.22	2.53	2.55	2.32	2.76	2.73	2.45	2.5	2.32	2.04	2.4	5.45	4.27	4.34
Quick Ratio	1.26	0.92	1.09	1.17	0.94	1.2	1.28	1.24	1.17	1.16	1.02	1.07	3.81	2.71	2.79
CFO/Avg Current Liab	0.81	0.8	0.74	0.76	0.85	0.61	0.62	0.59	0.44	0.9	0.7	0.5	0.68	1.05	1.3
Common Equity/Total Assets	79.88	54.1	55.71	58.25	59.85	52.84	60.83	57.58	54.06	57.59	63.08	68.78	51.69	57.03	58.99
Long-Term Debt/Equity (%)	8.61	59.64	58.87	49.28	42.39	63.1	38.3	40	53.13	43.26	28.46	21.54	73.15	56.86	51.17
Long-Term Debt/Capital (%)	7.93	36.75	36.49	32.51	29.33	38.22	27.13	28.1	34.25	29.75	21.84	17.44	42	36.08	33.7
Long-Term Debt/Total Assets (%)	6.88	32.26	32.8	28.71	25.37	33.34	23.3	23.03	28.72	24.91	17.95	14.81	37.81	32.43	30.18
Total Debt/Equity (%)	8.61	62.26	61.34	51.58	44.54	65.11	41.17	42.36	55.13	45.39	30.3	23.48	74.16	57.61	51.86
Total Debt/Capital (%)	7.93	38.37	38.02	34.03	30.81	39.43	29.17	29.76	35.54	31.22	23.25	19.02	42.58	36.55	34.15
Total Debt/Total Assets (%)	6.88	33.68	34.17	30.05	26.66	34.41	25.05	24.39	29.8	26.14	19.11	16.15	38.33	32.86	30.59
CFO/Total Liabilities	37.82	14.5	15.93	17.1	22.22	12.06	14.4	12.59	9.64	23.42	24.2	22	12.92	21.25	26.99
CFO/CapEx	0.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	6.37	3.28	3.6	3.96	4.04	4	5.42	4.98	3.33	4.67	5.75	7.13	4.55	5.82	5.44

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	9.23	8.39	7.91	7.67	7.58	8.01	7.82	7.27	6.8	6.38	7.19	7.26	7.34	7.37	7.7
Days Sales Outstanding	39.56	43.49	46.16	47.59	48.14	45.58	46.65	50.18	53.66	57.18	50.76	50.26	49.72	49.53	47.43
Inventory Turnover	2.97	2.75	3.05	3.27	3.1	2.99	2.91	2.77	2.66	2.66	2.81	2.59	2.36	2.34	2.43
Days Inventory Outstanding	122.78	132.82	119.65	111.73	117.81	122.11	125.42	131.95	137.32	137.42	130.03	140.92	154.42	156.08	150.14
Accounts Payable Turnover	9.5	7.91	8.26	10.44	9.46	10.31	13.31	11.92	10.87	10.24	11.63	10.89	10.58	10.64	12.48
Accounts Payable Turnover Days	38.44	46.12	44.2	34.98	38.59	35.41	27.43	30.62	33.57	35.63	31.38	33.51	34.49	34.3	29.25
Cash Conversion Cycle	123.9	130.19	121.61	124.34	127.36	132.28	144.64	151.51	157.41	158.97	149.41	157.67	169.65	171.31	168.33
Inventory to Cash Days	-83.23	-89.34	-73.49	-64.14	-69.67	-76.53	-78.76	-81.77	-83.65	-80.24	-79.26	-90.66	-104.7	-106.55	-102.72
Inventories	70	85	82	92	106	121	155	198	226	198	222	266	304	306	334
Raw Materials	26	30	33	34	38	46	56	65	74	68	67	89	120	111	111
Work In Process	6	6	6	8	9	11	13	14	18	19	22	30	25	27	32
Finished Goods	38	48	43	50	59	64	87	118	134	111	132	147	159	168	191
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	562	591	674	756	823	1,183	2,171	3,064	1,724	3,088	3,524	4,047	4,395	5,682	5,238
- Cash & Cash Equivalents	10	10	7	7	4	19	32	67	44	57	68	58	587	377	446
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	31	238	249	224	208	324	278	395	524	435	315	269	891	795	822
Enterprise Value	583	818	916	973	1,026	1,488	2,417	3,391	2,203	3,466	3,772	4,257	4,699	6,100	5,613
Total Capital	388	619	655	660	674	823	955	1,328	1,474	1,394	1,355	1,413	2,093	2,174	2,406
Total Debt/Capital (%)	7.93	38.37	38.02	34.03	30.81	39.43	29.17	29.76	35.54	31.22	23.25	19.02	42.58	36.55	34.15
Total Debt / EV	0.05	0.29	0.27	0.23	0.2	0.22	0.12	0.12	0.24	0.13	0.08	0.06	0.19	0.13	0.15
EV/Sales	1.62	2.08	2.04	1.91	1.89	2.46	3.32	3.84	2.21	3.6	3.51	3.7	3.74	4.5	3.7
EV/EBITDA	10.01	14.98	14.22	12.7	13.5	18.8	24.34	26.34	15.32	22.69	21.65	22.03	20.54	22.52	17.52
EV/EBIT	14.93	25.5	28.76	23.91	26.57	42.04	52.87	57.27	55.81	75.48	48.11	42.12	36.87	39.07	30.22
EV/Cash Flow to Firm	16.86	17.28	15.76	16.28	13.83	24.57	35.2	35.58	20.14	20.07	24.82	35.48	29.7	24.81	17.69
EV/Free Cash Flow to Firm	6.08	17.28	15.76	16.28	13.83	24.57	35.2	35.58	20.14	20.07	24.82	35.48	29.7	24.81	17.69
Diluted Market Cap	532	592	675	752	827	1,189	2,164	3,010	1,756	3,077	3,573	4,073	4,433	5,742	5,329
Diluted Enterprise Value	552	820	916	969	1,031	1,494	2,410	3,338	2,235	3,455	3,821	4,283	4,737	6,160	5,704
EV per Share	13.87	19.26	21.37	22.31	23.19	33.34	48.1	61.78	39.9	62.31	66.67	74.29	81.22	103.83	94.45
TTM Sales	359	394	449	510	542	604	728	883	995	964	1,075	1,151	1,257	1,357	1,516
TTM EBITDA	58	55	64	77	76	79	99	129	144	153	174	193	229	271	320
TTM Operating Income	39	32	32	41	39	35	46	59	39	46	78	101	127	156	186
TTM Cash Flow to Firm	35	47	58	60	74	61	69	95	109	173	152	120	158	246	317
TTM Free Cash Flow to Firm	96	47	58	60	74	61	69	95	109	173	152	120	158	246	317

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	5.58	12.62	13.14	14.11	11.91	22.18	34.5	34.78	22.56	18.62	24.27	35.63	30.54	26	17.92
EV/EBIT	14.93	25.5	28.76	23.91	26.57	42.04	52.87	57.27	55.81	75.48	48.11	42.12	36.87	39.07	30.22
Enterprise Value	583	818	916	973	1,026	1,488	2,417	3,391	2,203	3,466	3,772	4,257	4,699	6,100	5,613
Low Price	11.38	11.51	9.15	11.41	15.2	15.47	24.23	41.55	19.5	25.18	52.43	50.46	62.58	70.7	78.12
EV/Sales	1.62	2.08	2.04	1.91	1.89	2.46	3.32	3.84	2.21	3.6	3.51	3.7	3.74	4.5	3.7
EV/EBITDA	10.01	14.98	14.22	12.7	13.5	18.8	24.34	26.34	15.32	22.69	21.65	22.03	20.54	22.52	17.52
Price/Earnings	22.69	29.74	40.47	32.54	34.39	58.49	76.6	69.43	315.44	- -	72.19	53.84	46.34	46.78	40.58
Price/Earnings Average	25.34	28.88	33.41	26.63	37.88	46.31	63.74	65.9	460.88	-243.67	73.67	46.78	44.71	42.03	42.51
Price/Earnings High	33.82	32.89	43.92	33.22	48.88	59.26	81.39	82.53	643	-330.59	85.57	58.04	52.23	52.28	51.31
Price/Earnings Low	19.31	24.63	23.53	21.43	28.12	34.14	42.96	51.69	197.02	-141.81	60.75	38.47	38.18	34.2	35.97
Price/Book Value	1.57	1.55	1.66	1.74	1.77	2.37	3.21	3.28	1.81	3.22	3.39	3.54	3.66	4.12	3.31
Price/Book Value Average	1.76	1.5	1.37	1.42	1.94	1.88	2.67	3.12	2.65	2.51	3.46	3.07	3.53	3.7	3.46
Price/Book Value High	2.35	1.71	1.8	1.77	2.51	2.41	3.41	3.9	3.7	3.41	4.02	3.81	4.12	4.6	4.18
Price/Book Value Low	1.34	1.28	0.97	1.14	1.44	1.39	1.8	2.45	1.13	1.46	2.85	2.53	3.01	3.01	2.93
Price/Tangible Book Value	2.35	6.69	6.66	5.38	4.78	11.42	10.29	22.76	11.38	13.59	9.82	7.96	8.9	13.61	9.7
Price/Tangible Book Value Average	2.62	6.49	5.5	4.4	5.26	9.05	8.57	21.6	16.63	10.6	10.02	6.91	8.59	12.22	10.17
Price/Tangible Book Value High	3.5	7.39	7.23	5.49	6.79	11.57	10.94	27.05	23.2	14.38	11.64	8.58	10.03	15.2	12.27
Price/Tangible Book Value Low	2	5.54	3.87	3.54	3.91	6.67	5.77	16.94	7.11	6.17	8.27	5.68	7.33	9.95	8.6
Price/Sales	1.45	1.49	1.49	1.47	1.51	1.95	2.9	3.3	1.73	3.19	3.25	3.49	3.48	4.15	3.44
Price/Sales Average	1.62	1.44	1.23	1.2	1.66	1.54	2.41	3.14	2.53	2.49	3.32	3.03	3.36	3.73	3.6
Price/Sales High	2.17	1.64	1.62	1.5	2.15	1.97	3.08	3.93	3.52	3.38	3.86	3.76	3.92	4.64	4.35
Price/Sales Low	1.24	1.23	0.87	0.97	1.23	1.14	1.62	2.46	1.08	1.45	2.74	2.49	2.87	3.03	3.05
Price/Cash Flow	15.37	12.49	13.05	14.02	11.79	21.96	33.61	33.71	22.1	18.62	23.76	35.1	30.14	25.5	17.53
Price/Cash Flow Average	17.16	12.13	10.78	11.47	12.98	17.39	27.97	32	32.29	14.51	24.24	30.5	29.08	22.91	18.37
Price/Cash Flow High	22.91	13.81	14.17	14.31	16.75	22.25	35.71	40.07	45.04	19.69	28.16	37.84	33.97	28.5	22.17
Price/Cash Flow Low	13.08	10.34	7.59	9.23	9.64	12.82	18.85	25.1	13.8	8.45	19.99	25.08	24.83	18.64	15.54
Price/Free Cash Flow Average	6.23	12.25	10.85	11.54	13.12	17.56	28.71	33.02	32.97	14.51	24.77	30.96	29.47	23.36	18.77
Price/Free Cash Flow High	8.31	13.95	14.26	14.4	16.93	22.47	36.66	41.35	45.99	19.69	28.77	38.42	34.42	29.06	22.66
Price/Free Cash Flow Low	4.75	10.45	7.64	9.29	9.74	12.95	19.35	25.9	14.09	8.45	20.43	25.46	25.16	19.01	15.88
EV/Sales Average	1.8	2.03	1.78	1.64	2.05	2.06	2.82	3.67	3.01	2.89	3.58	3.24	3.61	4.07	3.87
EV/Sales High	2.39	2.23	2.17	1.94	2.53	2.49	3.51	4.5	4.01	3.78	4.12	3.97	4.18	4.99	4.62
EV/Sales Low	1.39	1.82	1.41	1.4	1.62	1.65	2.01	2.96	1.56	1.85	2.99	2.7	3.12	3.37	3.31
EV/EBITDA Average	11.13	14.67	12.4	10.91	14.59	15.69	20.67	25.13	20.84	18.23	22.07	19.28	19.87	20.39	18.3
EV/EBITDA High	14.74	16.13	15.12	12.9	18.05	19	25.71	30.83	27.76	23.85	25.4	23.67	22.99	24.98	21.84
EV/EBITDA Low	8.57	13.12	9.84	9.33	11.52	12.58	14.74	20.26	10.82	11.65	18.45	16.05	17.16	16.88	15.66
EV/EBIT Average	16.61	24.97	25.07	20.53	28.73	35.09	44.89	54.64	75.94	60.65	49.03	36.88	35.66	35.37	31.57
EV/EBIT High	21.99	27.45	30.57	24.29	35.55	42.49	55.83	67.03	101.15	79.35	56.44	45.25	41.25	43.34	37.68
EV/EBIT Low	12.78	22.34	19.89	17.56	22.69	28.13	32.02	44.05	39.42	38.74	40.99	30.69	30.79	29.28	27.02
Last Price	13.38	13.9	15.74	17.33	18.59	26.5	43.2	55.81	31.22	55.51	62.3	70.62	75.96	96.72	88.14
High Price	19.94	15.37	17.08	17.69	26.42	26.85	45.9	66.34	63.64	58.7	73.85	76.14	85.62	108.08	111.45
Enterprise Value Average	648	801	798	836	1,110	1,242	2,052	3,236	2,998	2,785	3,844	3,727	4,545	5,522	5,862
Enterprise Value High	858	881	973	989	1,373	1,504	2,553	3,969	3,993	3,643	4,425	4,574	5,258	6,767	6,998
Enterprise Value Low	499	717	633	715	876	996	1,464	2,609	1,556	1,779	3,213	3,102	3,925	4,571	5,017

Shares Outstanding	42	42	43	44	44	45	50	55	55	56	57	57	58	59	59
Diluted Weighted Avg Shares	40	43	43	43	45	45	50	54	56	55	57	58	58	59	60
Basic Weighted Avg Shares	39	42	43	43	44	44	49	52	55	55	56	57	58	58	59
Revenue per Share	9.2	9.35	10.54	11.81	12.31	13.6	14.91	16.89	18.06	17.39	19.14	20.26	21.83	23.3	25.62
EBITDA per Share	1.49	1.3	1.51	1.78	1.73	1.78	2.03	2.46	2.61	2.76	3.1	3.4	3.97	4.65	5.42
Operating Income per Share	1	0.76	0.75	0.94	0.88	0.8	0.94	1.13	0.72	0.83	1.4	1.78	2.21	2.68	3.14
Basic EPS, GAAP	0.59	0.47	0.39	0.53	0.54	0.45	0.56	0.8	0.1	-0.18	0.86	1.31	1.64	2.07	2.17
Basic EPS from Cont Ops	0.59	0.47	0.39	0.53	0.54	0.45	0.56	0.8	0.1	-0.18	0.86	1.31	1.64	2.07	2.17
Diluted EPS, GAAP	0.58	0.46	0.39	0.53	0.53	0.45	0.55	0.78	0.1	-0.18	0.84	1.29	1.62	2.03	2.13
Diluted EPS from Cont Ops	0.58	0.46	0.39	0.53	0.53	0.45	0.55	0.78	0.1	-0.18	0.84	1.29	1.62	2.03	2.13
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.87	1.11	1.21	1.24	1.58	1.21	1.29	1.66	1.41	2.98	2.62	2.01	2.52	3.79	5.03
Free Cash Flow per Basic Share	-0.7	1.11	1.21	1.24	1.58	1.21	1.29	1.66	1.41	2.98	2.62	2.01	2.52	3.79	5.03
Cash & Equivalents per Share	0.24	0.23	0.17	0.17	0.09	0.43	0.64	1.23	0.8	1.02	1.2	1.02	10.15	6.41	7.51
Book Value per Share	8.5	8.98	9.47	9.98	10.53	11.16	13.46	16.99	17.21	17.23	18.38	19.97	20.78	23.48	26.66
Tangible Book Value per Share	5.7	2.08	2.36	3.22	3.89	2.32	4.2	2.45	2.74	4.08	6.34	8.88	8.54	7.11	9.08

Merit Medical Systems, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)